Abstract
The effect of lithium on the phosphoinositide-signaling pathway was examined in 5-HT2C receptors, which are involved in phospholipase C stimulation, expressed in Xenopus laevisoocytes by voltage-clamp recording and assay of intracellular Ca2+ concentrations. Treatment with lithium for 60 sec after the initial application of 5-HT reduced Ca2+-dependent chloride currents in a dose-dependent manner (0.01–1 mm) and inhibited intracellular Ca2+release, whereas pretreatment with lithium or injection into oocytes had no effect. Additionally, treatment with lithium for more than 24 hr reduced 5-HT-evoked currents to a much lesser extent. In contrast, the currents through other phosphoinositide-dependent receptors, such as endogenous “serum” and muscarinic ACh receptors, were not affected or less affected by a short term or long term treatment with lithium, respectively. These results indicate that lithium may have a specific blocking effect on the 5-HT2C receptors and, in part, nonselectively act on the phosphoinositide metabolic pathway.
Footnotes
-
Send reprint requests to: Dr. Tomoyuki Nishizaki, Department of Physiology, Kobe University School of Medicine, 7–5-1 Kusunoki-cho, Chuo-ku, Kobe 650, Japan.
- Abbreviations:
- 5-HT
- 5-hydroxytryptamine (serotonin)
- ACh
- acetylcholine
- BAPTA
- 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid, tetrapotassium salt, hydrate
- HEPES
- 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
- Received July 3, 1996.
- Accepted November 14, 1996.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|